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Abstract
Rationale: Asthma has been reported to be more prevalent among
Hispanics of Puerto Rican heritage than among other Hispanics and
among Hispanics born in the United States or who immigrated as
children than among those who came as adults; however, direct
comparisons across Hispanic groups are lacking.
Objectives: To test whether asthma is more prevalent among
Hispanics of Puerto Rican heritage than among other Hispanic
groups, whether asthma is associated with age of immigration,
and whether chronic obstructive pulmonary disease varies by heritage
in a large, population-based cohort of Hispanics in the United States.
Methods: The Hispanic Community Health Study/Study of Latinos
researchers recruited a population-based probability sample of 16,415
Hispanics/Latinos, 18–74 years of age, in New York City, Chicago,
Miami, and SanDiego. Participants self-reported Puerto Rican, Cuban,
Dominican, Mexican, Central American, or South American heritage;
birthplace; and, if relevant, age at immigration. A respiratory
questionnaire and standardized spirometry were performed with post-
bronchodilator measures for those with airflow limitation.
Measurements and Main Results: The prevalence of physician-
diagnosed asthma among Puerto Ricans (36.5%; 95% confidence
interval, 33.6–39.5%)washigher thanamongotherHispanics (odds ratio,
3.9; 95% confidence interval, 3.3–4.6). Hispanics who were born in the
mainland United States or had immigrated as children had a higher
asthma prevalence than those who had immigrated as adults (19.6, 19.4,
and 14.1%, respectively; P, 0.001). Current asthma, bronchodilator
responsiveness, and wheeze followed similar patterns. Chronic
obstructive pulmonary disease prevalence was higher among Puerto
Ricans (14.1%)andCubans (9.8%) thanamongotherHispanics (,6.0%),
but it didnot vary acrossHispanic heritages after adjustment for smoking
andprior asthma (P = 0.22), by countryofbirth, orbyageat immigration.
Conclusions: Asthma was more prevalent among Puerto
Ricans, other Hispanics born in the United States, and those
who had immigrated as children than among other Hispanics. In
contrast, the higher prevalence of chronic obstructive pulmonary
disease among Puerto Ricans and Cubans was largely reflective of
differential smoking patterns and asthma.
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Hispanics are the largest and fastest-
growing minority population in the United
States, accounting for 17% of the U.S.
population currently and projected to
represent an estimated 30% of the U.S.
population by 2050 (1). Over one-third of
U.S. Hispanics were born outside the
United States, and approximately one-half
of immigrants to the United States are
Hispanic (2, 3).
Asthma is the leading cause of
hospitalization among young adults in the
United States of Hispanic and non-Hispanic
ethnicity (4, 5). Several studies suggest that
persons in and from Puerto Rico, an
unincorporated territory of the United
States, have a particularly high prevalence
of asthma (4, 6–10). However, direct
comparisons between Hispanics of different
heritages are not available, except in smaller
studies that do not allow confident
conclusions to be drawn about possible
differences in respiratory disease across
Hispanic groups.
Puerto Ricans move to the mainland
United States at a younger age, on average,
than other Hispanics, potentially resulting
in earlier exposures and acculturation in the
United States, and they may be subject to
more Americanized exposures in Puerto
Rico than Hispanics who emigrate from
other countries. Early life exposures have
been implicated in the pathogenesis of
asthma due to effects on innate and adaptive
immunity (11). Given that immigration to
the United States implies a change in
environmental and allergen exposures,
birth in the United States and immigration
to the United States at an early age may
affect asthma risk. Indeed, some U.S.
studies suggest a higher risk of asthma
among Hispanics born in the United States
than in those who immigrated to the
United States (6, 12–15); however, these
studies have generally been small or have
focused on Hispanics of one heritage.
Chronic obstructive pulmonary disease
(COPD) is the third leading cause of death
in the United States. COPD mortality is
lower among Hispanics than among
non-Hispanics (16), in part due to lower
prevalence of cigarette smoking in some
Hispanic groups (17). Some studies have
suggested that some Hispanics may be at
reduced risk of COPD (18, 19), whereas
others found no difference by ancestry (20)
and after adjustment for smoking (21). The
prevalence of spirometry defined COPD
across the major Hispanic groups,
particularly in relation to smoking and
asthma, has not been described.
We therefore examined the prevalence
of asthma and COPD in the HCHS/SOL
(Hispanic Community Health Study/Study
of Latinos), hypothesizing that asthma
would be more prevalent among Puerto
Ricans than among Hispanics of other
heritages and among other Hispanics who
were born in or had immigrated to the
United States as children than among those
who had immigrated as adults. Some of the
results we report were previously presented
in abstract form (22).
Methods
The HCHS/SOL is a community-based
probability sample cohort study designed
to examine risk factors of chronic disease
among Hispanics of Mexican, Puerto
Rican, Cuban, Dominican, Central
American, and South American heritages
living in the United States (23, 24). The
HCHS/SOL researchers recruited and
evaluated 16,415 self-identified Hispanics/
Latinos ages 18–74 years between 2008
and 2011 in four U.S. communities
(Bronx, NY; Chicago, IL; Miami, FL; and
San Diego, CA). Households were selected
using a stratified, two-stage area
probability sample design with
oversampling to increase the likelihood
that a selected address would yield a
Hispanic/Latino household (23). Of 39,384
individuals who were screened and
selected and who met the eligibility
criteria, 16,415 Hispanics (41.7%) from
9,872 households were enrolled. The study
oversampled those ages 45–74 years to
facilitate examination of target outcomes.
As HCHS/SOL recruited only
Hispanics, we compared prevalence
estimates in the MESA (Multi-Ethnic Study
of Atherosclerosis), in which investigators
recruited a multiethnic sample ages 45–84
years without clinical cardiovascular disease
between 2000 and 2002 (25). MESA
conducted examinations between 2010 and
2012 with pulmonary measures identical to
those used in HCHS/SOL. The studies were
approved by the institutional review boards
at each participating institution, and
written informed consent was obtained
from all participants.
Self-reported Diagnoses and
Symptoms
A standard respiratory questionnaire (26)
was used to ascertain respiratory diagnoses
and symptoms. Physician-diagnosed asthma
was defined by affirmative responses to the
items “Have you ever had asthma?” and
“Was it diagnosed by a doctor or other
healthcare professional?” Current asthma
was defined as physician-diagnosed asthma
with the use of an asthma treatment within
the previous 12 months.
Wheeze was defined as ever having had
“an attack of wheezing or whistling in your
chest that made you feel short of breath,”
and dyspnea was defined by a positive
response to the item “Are you troubled by
shortness of breath when hurrying on level
ground or walking up a slight hill?”
Items were translated into Spanish and
confirmed with focus groups.
At a Glance Commentary
Scientific Knowledge on the
Subject: Asthma has been reported to
be more prevalent among Hispanics of
Puerto Rican heritage and Hispanics
born in the United States, and some
studies have suggested that Hispanics
of Mexican heritage may have a lower
risk of chronic obstructive pulmonary
disease (COPD); however, direct
comparisons across Hispanic groups
are lacking.
What This Study Adds to the
Field: Asthma was up to three times
more common among Hispanics of
Puerto Rican heritage than among
other Hispanics. Hispanics who were
born in the mainland United States or
immigrated to the United States as
children had a higher asthma
prevalence than those who immigrated
as adults. In contrast, the prevalence of
COPD did not differ by Hispanic
heritage after accounting for smoking
patterns and asthma earlier in life
(onset before age 45 yr). These findings
suggest that exposure to a more
Americanized environment or lifestyle
at a young age may contribute to
asthma in Hispanics and suggest that
differences in COPD prevalence across
Hispanic groups is due mostly to
variation in the prevalence of cigarette
smoking and asthma earlier in life.
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Place of Birth and Age of Immigration
Heritage was identified by asking, “Which
best describes your Hispanic/Latino
heritage?” Participants were asked, “In what
country or territory were you born?”
Separate codes were recorded for “United
States,” “Puerto Rico,” and “other
countries.” The age at immigration into the
mainland United States was defined as
current age minus the number of years
living in the United States, assessed by the
item “From the time that you FIRST moved
to the United States to today, about how
many years have you lived in the mainland
United States (50 states 1 DC)?” The
mainland United States was defined as the
50 U.S. states and Washington, DC.
Childhood versus adult immigration was
dichotomized at 16 years of age.
Spirometry
Spirometry was conducted in accordance
with American Thoracic Society/European
Respiratory Society guidelines (27) using
a dry rolling sealed spirometer with
automated quality checks (Occupational
Marketing, Houston, TX) according to the
MESA-Lung study protocol (28) with
overreading by one investigator. All
participants, except those with recent
cardiovascular events or surgery, were
asked to perform prebronchodilator
spirometry. Participants with
prebronchodilator FEV1/FVC ratios less
than 0.70 or less than the lower limit of
normal (29) met the criteria to perform
post-bronchodilator spirometry.
COPD was defined by a post-
bronchodilator FEV1/FVC ratio less than
0.70 (30). A positive bronchodilator
response was defined as an increase in the
FEV1 of 200 milliliters or greater and an
increase in FEV1% predicted of 12% or
greater.
Covariates
Information on demographics, education,
income, health insurance, and smoking was
obtained by questionnaire. Never smoking
was defined as smoking fewer than 100
cigarettes ever, and current smoking was
defined as self-reported smoking of a
cigarette in the previous 30 days. Height and
weight were measured following a
standardized protocol. Acculturation was
assessed on the basis of two factors from the
Short Acculturation Scale for Hispanics
(31)—one on language preference and the
other on social relationships—and an item
on Hispanic compared with American food
preference, as previously described (32).
Statistical Analysis
Prevalence estimates were calculated and
weighted to adjust for disproportionate
selection probabilities and to adjust for bias
due to differential nonresponse at the
household and person levels (23, 24). All
analyses accounted for cluster sampling and
the use of stratification in sample selection.
Estimates are applicable to the study target
population, defined as Hispanics/Latinos
ages 18–74 years living in the four study
communities.
Prevalence estimates were stratified by
Hispanic heritage using survey logistic
regression–predicted marginals, which
adjusted each subgroup to the target
population distribution of age, sex,
education, health insurance, years in the
United States, smoking status, and body
mass index. As certain Hispanic/Latino
heritages tended to be concentrated in
specific geographic areas, not all heritages
were present in each study site, creating the
possibility of confounding between heritage
and site. We therefore examined for
possible site effects by fitting additional
survey logistic regression models, adjusting
for a 17-level heritage-by-site interaction
term in place of heritage.
Prevalence estimates of COPD were
restricted to participants age 45 years and
older. Prevalence estimates of
bronchodilator responsiveness were
restricted to participants with airflow
limitation. Missing assessments of COPD
and bronchodilator responsiveness were
accounted for using a three-step process.
Missing data for prebronchodilator
spirometry were accounted for by inverse
probability weighting. Weights were
developed using a logistic regression
model from a set of baseline covariates.
COPD and bronchodilator responsiveness
for participants with missing post-
bronchodilator spirometry data along with
sporadic missing data for covariates were
then estimated with multiple imputation
using inverse probability weighting. See
Table E1 in the online supplement for
details. Analyses in MESA proceeded in a
similar fashion but were unweighted.
All analyses were performed using SAS
version 9.2 (SAS Institute, Cary, NC) and
SUDAAN release 11.0.0 (RTI International,
Research Triangle Park, NC) software.
Results
The HCHS/SOL research team recruited
16,415 participants, of whom 98.2%
completed the respiratory questionnaire
(Figure E1). Hispanics of Mexican heritage
were recruited predominantly in San Diego
and Chicago, Puerto Ricans in New York
City and Chicago, Cubans in Miami,
Dominicans in New York City, and Central
and South Americans inMiami and Chicago
(Table E2).
Prebronchodilator spirometry was
completed by 94.1% of participants, and
post-bronchodilator spirometry by 1,073
(76% of those selected). Participants with
spirometry measures were modestly
younger, better educated, and more likely to
be male and uninsured compared with those
who did not complete spirometry (Table
E3).
The estimated Hispanic heritage in the
four communities was 38% Mexican, 16%
Puerto Rican, 20% Cuban, 7% Central
American, 10% Dominican, 5% South
American, and 4% other or mixed. Forty-
eight percent were male, and 50% were older
than 45 years of age. Twenty-one percent
currently smoked cigarettes, and 17% had
previously smoked cigarettes. Twenty-three
percent were born in the mainland United
States, 15% had moved to the United States
as children, and 63% had moved to the
United States as adults.
Table 1 shows participant
characteristics stratified by Hispanic
heritage. Cubans were older than the
overall average, and a higher proportion
of Dominicans were women. Education
varied modestly, and health insurance
varied appreciably, across heritages.
Approximately half of Puerto Ricans and
those of other or mixed heritages had been
born in the continental United States, a
much greater proportion than others, and
more Puerto Ricans and Dominicans had
moved to the mainland United States as
children. Smoking was most common
among Puerto Ricans, followed by Cubans
and other or mixed heritages.
Prevalence of Asthma by Hispanic
Heritage
The prevalence of physician-diagnosed
lifetime asthma among Hispanics was
16.4% (95% confidence interval [CI],
15.4–17.4), and the prevalence of current
asthma was 7.4% (95% CI, 6.8–8.1). The
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prevalence of asthma varied by Hispanic
heritage (P, 0.001) and was highest
among Puerto Ricans; intermediate
among Cubans, Dominicans, and other or
mixed heritage groups; and lowest among
Mexicans (Table 2). The age- and sex-
adjusted odds ratio for asthma among
Puerto Ricans compared with Hispanics
of other heritages was 3.9 (95% CI,
3.3–4.6). These differences changed little
in the fully adjusted analysis (Table 2).
Additional adjustment for three measures
of acculturation made no material
differences to the results; for example, the
acculturation-adjusted prevalence of
asthma was 31.0% among Puerto Ricans
and 7.7% among Mexicans. Similar
differences across Hispanic heritages were
observed for current asthma, symptoms
of wheezing that resulted in shortness
of breath, wheeze in the previous
12 months, dyspnea, and bronchodilator
responsiveness, although the last item did
not attain statistical significance (Table 2;
Table E4). The findings for asthma and
bronchodilator responsiveness were little
changed among never smokers
(Table E5).
The prevalence of asthma varied by site
and was particularly high in New York City
(Figure E2). Most Puerto Ricans were
recruited in New York City, which might
have accounted for the difference by
Hispanic heritage. However, the prevalence
of asthma among Puerto Ricans in New
York City was higher than that among
Dominicans and others also recruited in
New York City, and the prevalence of
asthma was much higher in Puerto Ricans in
Chicago than among all other Hispanics in
Chicago (Figure E2).
Age at Immigration and Asthma
The adjusted prevalence of asthma among
Hispanics who had immigrated to the United
States as adults was 14.1% compared with
19.4% among those who had immigrated as
children and 19.6% among those who were
born in the United States (Table 3). These
differences were independent of age, sex,
educational attainment, smoking status, body
mass index, and health insurance, which
differed across these groups (Table E6), and
persisted among never smokers (P = 0.001).
Among Hispanics who immigrated to the
United States, the prevalence of asthma was
highest among those who immigrated in
early childhood compared with those who
had immigrated as adults, with an inflection
point between ages 5 and 15 years (Figure 1).
Table 3. Prevalence Estimates of Physician-diagnosed Asthma and Bronchodilator Responsiveness from the Hispanic Community
Health Study/Study of Latinos by Age at Immigration to the United States
Born in United States Immigrated at Age 0–15 Yr Immigrated at Age >15 Yr P Value
Sample size 2,083 2,035 11,271
Physician-diagnosed asthma, ever
Multivariate analysis 19.6 (17.3–22.0) 19.4 (16.9–22.2) 14.1 (13.0–15.3) ,0.001
Physician-diagnosed asthma, current
Multivariate analysis 9.5 (8.0–11.3) 8.5 (6.9–10.5) 6.0 (5.3–6.7) ,0.001
Bronchodilator responsiveness
Sample size 215 120 735
Multivariate analysis 24.5 (13.5–39.8) 13.2 (2.7–42.1) 10.7 (5.7–18.8) 0.269
Second multivariate analysis 26.0 (15.0–41.0) 11.8 (2.6–36.9) 10.7(5.7–18.9) 0.239
Ninety-five percent confidence intervals are shown in parentheses. Sample size represents number completing the respiratory questionnaire (or
post-bronchodilator spirometry) from which the population estimates are derived. All estimates account for sampling weight and study design. P values
comparing age of immigration categories are derived from a survey logistic regression Wald F test with 2 numerator degrees of freedom. Multivariate
model adjusted for age, sex, educational attainment, age at immigration, 10 or more years in the United States, smoking status, body mass index, and
health insurance. Second model for bronchodilator responsiveness was not adjusted for health insurance but was additionally adjusted for current
pulmonary medication use and prebronchodilator FEV1.
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Figure 1. Estimated prevalence of asthma by age at immigration to the continental United States.
The gray vertical lines represent 95% confidence intervals around the point estimates of asthma
prevalence at each year of age of immigration adjusted for age, sex, and Hispanic heritage. The black
line is the cubic smooth spline curve fitted across the point estimates.
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Current asthma and bronchodilator
responsiveness were also higher among
participants who had immigrated as
children and those who were born in the
United States than in the other groups
(Table 3), although the differences were not
statistically significant for bronchodilator
responsiveness.
The association of age of immigration
with current asthma was modified by
Hispanic heritage (P = 0.004 for interaction).
Figure E3 shows large, monotonic
differences in current asthma prevalence by
age at immigration among Central
Americans and Mexicans (both P, 0.05);
consistent but nonsignificant associations
among Cubans, Dominicans, and other or
mixed heritages; and no evidence for
association among Puerto Ricans and South
Americans. The findings were similar for
ever having had asthma (Figure E4). There
was little or no evidence for effect
modification by site (P-interaction = 0.87
and P = 0.06, respectively), with similar
findings across all sites (Figure E5).
Wheeze that contributed to shortness
of breath was also lower among Hispanics
who had immigrated to the United States at
age 16 years or older (12.5%) than in those
who had immigrated before age 16 years
(15.9%) or among those who were born in
the United States (17.6%; P, 0.001). The
findings were similar for current wheeze
and, with more variation, dyspnea (Table
E7).
COPD
The prevalence of COPD among
participants older than 45 years of age was
8.2% (95% CI, 7.1–9.5). The age- and sex-
adjusted prevalence of COPD differed by
Hispanic heritage (P, 0.001) and was
higher among Puerto Ricans and Cubans
and compared with others (Table 4).
However, differences were attenuated by
adjustment for smoking history and asthma
with onset before age 45 years resulting in
no differences in COPD prevalence by
Hispanic heritage in the fully adjusted
model (Table 4). These findings were
similar in analyses restricted to participants
with 10 or more pack-years of smoking
(Table E8).
There was no evidence that age at
immigration was associated with COPD.
The adjusted prevalence of COPD was
7.8% (95% CI, 6.9–8.8%) among
Hispanics who had immigrated to the
United States as adults, 11.1% (95% CI,
6.4–18.7%) among those who had
immigrated as children, and 8.1% (95%
CI, 5.1–12.5%) among those who were
born in the mainland United States
(P = 0.46 for trend).
Comparisons in MESA
The prevalence of asthma among
Hispanics of Mexican heritage in MESA
was 8.8%, similar to that in HCHS/SOL.
The prevalence of asthma was somewhat
higher in non-Hispanic whites and non-
Hispanic African Americans than
Hispanics of Mexican heritage in MESA
(Table E9), but it was not nearly as high as
that among Puerto Ricans, Cubans, and
Dominicans in HCHS/SOL. A similar but
less marked pattern was present for the
prevalence of wheezing in the previous
12 months. The prevalence of COPD
among Hispanics in HCHS/SOL was
not dissimilar from that among
non-Hispanics in MESA.
Discussion
In this large, population-based U.S. study,
Puerto Ricans had a threefold higher
prevalence of asthma compared with
Hispanics of other heritages. Among
non–Puerto Rican Hispanics, those who
were born in United States or who had
immigrated to the United States as children
had a higher prevalence of asthma than
those who immigrated as adults. The
findings were similar for bronchodilator
responsiveness and wheeze. In contrast,
there was no evidence that prevalence of
COPD differed by Hispanic heritage or
varied by age at immigration after
accounting for differences in smoking and
asthma history.
The present study is by far the largest
on this topic to report on Hispanics of
multiple heritages. The noted high
prevalence of asthma among Puerto Ricans
is consistent with prior smaller studies that
showed a prevalence of 12–26% in Puerto
Ricans compared with the U.S. national
prevalence of approximately 8% (4, 5, 7, 8)
and in a large, nationally representative
sample (15). Unlike prior studies on this
topic, the present findings were not
potentially due to selection bias, differences
by site, or diagnostic bias, as noted by the
consistent findings for bronchodilator
responsiveness and symptoms of wheezing.
The low prevalence among those from
Mexico, Central America, and South
America is consistent with evidence that
asthma is less common among Mexican
Table 4. Prevalence Estimates of Chronic Obstructive Pulmonary Disease for Participants Ages 45 Years and Older from the
Hispanic Community Health Study/Study of Latinos
Mexican Puerto Rican Cuban
Central
American Dominican
South
American
Other or
Mixed P Value
Sample size 3,383 1,547 1,454 873 760 604 195
Age and sex
adjusted
4.6 (3.6–6.0) 14.1 (9.9–19.6) 9.8 (8.3–11.6) 5.2 (3.6–7.3) 5.6 (3.6–8.4) 5.9 (3.7–9.5) 5.1 (2.0–12.0) , 0.001
Multivariate analysis 5.5 (4.3–7.1) 12.6 (9.3–16.8) 8.4 (6.8–10.2) 6.2 (4.3–8.9) 7.1 (4.6–10.8) 6.8 (4.4–10.4) 5.5 (2.2–12.7) 0.002
Second multivariate
analysis
6.5 (5.1–8.2) 11.1 (7.9–15.3) 8.0 (6.6–9.7) 6.6 (4.6–9.3) 7.5 (5.0–11.1) 7.2 (4.8–10.8) 5.8 (2.3–13.4) 0.223
Ninety-five percent confidence intervals are shown in parentheses. Sample size represents participants age 45 years and older completing
prebronchodilator spirometry and post-bronchodilator spirometry, when indicated, from which the population estimates are derived. P value comparing
backgrounds is from a survey logistic regression Wald F test with 6 numerator degrees of freedom. Multivariate analysis is adjusted for age, sex,
educational attainment, age at immigration, 10 or more years in the United States, smoking status, pack-years of smoking, and health insurance. Second
multivariate model is adjusted for all items in the multivariate analysis except health insurance plus asthma onset before age 45 years.
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Americans than among non-Hispanic
whites (6, 12), similar to the comparisons
with MESA reported here and a prior study
including Central Americans and South
Americans (33).
Asthma prevalence was high among
Puerto Ricans who were born in the
mainland United States and Puerto Rico,
regardless of age at migration. In contrast,
other Hispanics who were born in the
United States or who had immigrated to
the United States as children had a higher
prevalence of asthma than those who
had immigrated to the United States as
adults. Prior studies have found similar
associations in Mexican Americans
(12–15, 34) and, recently, in non-
Hispanic whites and African Americans
(15). Similar findings have been reported
for immigrants to Great Britain, Sweden,
and, more variably, Israel (35–37).
In contrast, there was no suggestion
that COPD prevalence was related to either
Hispanic heritage or age at immigration
after accounting for history of smoking and
a prior history of asthma. In studies from
the United States, Central America, and
South America, researchers have found a
lower prevalence of COPD among Mexican
Americans compared with non-Hispanic
Americans (16, 38, 39) and among
Mexicans compared with South Americans
(40), although much of these differences
was attributable to smoking patterns. In
the present study, the largest on the topic
to date, the higher prevalence of COPD
among Puerto Ricans and Cubans was
largely explained by differences in
smoking patterns and asthma earlier in
life. Mexican Americans had the lowest
prevalence of all groups; however, the
multivariate 95% CI for Mexican
Americans included the prevalence
estimates of all other groups except Puerto
Ricans, and there was no evidence for
differential COPD prevalence in the
multivariate results.
The mechanisms behind the higher
prevalence of asthma among Puerto
Ricans and other Hispanics of Caribbean
origin were not examined in detail in the
present study but may include greater
exposure to active and passive tobacco
smoke (41); a greater predisposition to
allergic disease, including rhinitis, eczema
(42), and atopy (43, 44); environmental
exposures (43, 45); premature birth (46);
other socioeconomic factors (47); and
genetic (18, 48) and epigenetic (49)
factors. Early life exposures may also be
implicated (41), which is supported by
our findings of the markedly elevated risk
of asthma among Hispanics who had
immigrated to the United States before
age 6 years. Early-life exposures
encountered in predominantly urban U.S.
environments may include increased
dust, cockroach- and mold-borne
allergens, and air pollution exposures
(45), which may increase the risk of
developing asthma via eosinophilic and
noneosinophilic mechanisms (50).
Acculturation has also been suggested to
play a role in asthma development (15).
However, in the present study, measures
of acculturation based upon language,
social factors, and food preferences had
little impact on the results, possibly
because they were collinear with items
already in the model, such as years in the
mainland United States.
Evidence for contributions of both
genetic and nongenetic factors to asthma
is suggested by its higher prevalence
among Puerto Ricans than in
Dominicans and other Hispanics in the
Bronx and also than Mexicans and other
Hispanics in Chicago in addition to its
considerably higher prevalence among
Puerto Ricans in the Bronx compared with
Chicago.
Although the present study is the
largest population-based study of
Hispanics in the United States,
particularly one that includes post-
bronchodilator spirometry measures, it
has a number of limitations. First, the
sample was drawn predominantly from
urban settings, and hence the results may
not fully capture respiratory disease
related to nonurban exposures. Whereas
asthma prevalence may be lower in rural
than in urban settings, COPD might be
higher (51). Furthermore, residents of
Puerto Rico and Hispanics in the U.S.
Southwest were not included in the
HCHS/SOL. The response rate to the
study was modest, and not all participants
completed spirometry. However, we used
two-stage weighted and multiple
imputation to account for missing data;
therefore, the estimates are likely to be
reasonably accurate. A control group of
non-Hispanics was not included in the
original design; however, we included
results for Hispanics and non-Hispanics
in MESA, in which researchers
ascertained respiratory disease in an
identical manner in the same time period
in two of the same cities as HCHS/SOL,
although the strategy and years of cohort
recruitment differed. Hispanic heritage
was based upon self-report, which has
limitations but is a reasonable standard;
subsequent work will evaluate heritage
including ancestral markers. Asthma was
also defined by self-report of a physician’s
diagnosis, which may be subject to
bias, and there is some degree of
misclassification with COPD. However,
the results for asthma restricted to never
smokers and COPD restricted to
participants with 10 or more pack-years
yielded findings that were highly
consistent with those from the overall
cohort.
In conclusion, asthma prevalence was
high in Puerto Ricans, regardless of
place of birth and age at immigration.
Among other Hispanics, birth in the
United States, and particularly
immigration to the United States as a
child, was associated with elevated asthma
risk. Consistent associations were
observed for symptoms of wheeze and
bronchodilator responsiveness, and there
was no relationship between age at
immigration and COPD after adjustment
for smoking, demonstrating a specific
association likely not due to diagnostic
bias. In contrast, differences in COPD
prevalence across Hispanic heritages
in this study were fully explained by
smoking patterns and asthma earlier in
life. These findings suggest that exposure
to the U.S. environment or lifestyle at a
young age may contribute to asthma and
that differences in smoking and asthma
drive much of the variation in COPD
prevalence across different Hispanic
groups. n
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